2017 - A Vast Unmet Need: Challenges in Alzheimer’s Clinical Trials
Date2017-11-14
Deadline2017-11-13
VenueOnline, Canada
KeywordsAlzheimer's Disease; Drug Development; Clinical Trials
Topics/Call fo Papers
Dementia is a growing global epidemic, affecting nearly 47 million people worldwide. That number is expected to approach 75 million by 2030, when the cost of patient care is forecast to reach $2 trillion. And the trend will only accelerate: By 2050, it’s estimated that 115 million will suffer from some form of dementia. Alzheimer’s disease is by far the most common of these afflictions occurring late in life, making it imperative that we develop new pharmacologic therapies.
Other CFPs
Last modified: 2017-11-11 01:55:22